Coronavirus / COVID

The US will initiate travel restrictions beginning May 4th, due to the surging COVID-19 case load in India.

The report details what symptoms vaccinated people should look out for, as well as treatment details for healthcare professionals.

While a slightly higher rate of morbidity was observed, a small percentage of babies presented with COVID-19 after birth.

A prolonged infection can allow a virus to mutate more often, potentially letting more transmissible variants to emerge.

Pre-existing conditions were found to increase the risk of COVID-19 related death in those with diabetes.

The confusion and uncertainty surrounding the need for a second dose among the public shows the need for better guidance from the medical community.

Patients who received the inhaled glucocorticoid budesonide in the first several days of COVID-19 symptoms were much less likely to require hospital care.

The most common symptoms were headache, fatigue and soreness at the injection site.

A pair of recent studies suggest that the ability of people with blood cancers lymphocytic leukemia and multiple myeloma to produce antibodies in response to COVID-19 vaccines is impaired.

Surveys suggest most students plan to get the shots anyway.

The discovery of these nanobodies may help to create treatments that can protect against COVID-19, as well as future variants of the virus.

Individuals who are fully vaccinated can shed their masks when exercising outdoors and gathering in small groups.

Exposure to a segment of the viral spike protein induced COVID-19 like symptoms and caused lung damage similar to those with the disease.

Even in mild cases, symptoms of COVID-19 can linger for at least 8 months, according to new research.

The Biden Administration plans to donate the AstraZeneca vaccines globally upon clearance of safety reviews.

Thailand steps up travel restrictions among a rapidly spreading third wave of the disease.

Nursing home residents who had recovered from COVID-19 showed robust antibody levels against the SARS-CoV-2 spike protein after 1 dose of messenger RNA (mRNA) vaccine, a study in France showed.

CDI prevalence among those hospitalized with a COVID-19 infection was not found to be increased despite more use of antibiotics.

The Advisory Committee on Immunization Practices voted 10-4 with 1 abstention to resume the rollout and administration of the Janssen shot.

The 6th major component of the 1-year old ACTIV public-private initiative of the NIH will test candidate drugs to repurpose for COVID-19.

Providing support to communities of color could encourage participation and improve uptake.

While the addition of outside air into a building showed a clear benefit, too much air exchange can have a negative impact.

New analysis of registry data suggest pregnant persons are not facing particularly worse pregnancy nor neonatal outcomes after mRNA vaccination.

Two cases in the United States showed reinfection after administration of the m-RNA vaccines may complicate protection against new variants, but lend support to a potential need for a booster.

The Johnson & Johnson shot showed an efficacy of 66.9% and 66.1% on the 2 primary endpoints, with a higher efficacy against severe-critical disease.